These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33371667)

  • 1. Architectured Therapeutic and Diagnostic Nanoplatforms for Combating SARS-CoV-2: Role of Inorganic, Organic, and Radioactive Materials.
    Pandey A; Nikam AN; Mutalik SP; Fernandes G; Shreya AB; Padya BS; Raychaudhuri R; Kulkarni S; Prassl R; Subramanian S; Korde A; Mutalik S
    ACS Biomater Sci Eng; 2021 Jan; 7(1):31-54. PubMed ID: 33371667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic.
    Bhutta ZA; Kanwal A; Ali M; Kulyar MF; Yao W; Shoaib M; Ashar A; Mahfooz A; Ijaz M; Ijaz N; Asif M; Nawaz S; Mahfooz MR; Kanwal T
    Nanotechnology; 2021 Sep; 32(48):. PubMed ID: 34320471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2.
    Derakhshan MA; Amani A; Faridi-Majidi R
    ACS Appl Mater Interfaces; 2021 Apr; 13(13):14816-14843. PubMed ID: 33779135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations.
    Rai M; Bonde S; Yadav A; Bhowmik A; Rathod S; Ingle P; Gade A
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34202815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view.
    Chatterjee S; Mishra S; Chowdhury KD; Ghosh CK; Saha KD
    Life Sci; 2021 Aug; 278():119580. PubMed ID: 33991549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
    Khade SM; Yabaji SM; Srivastava J
    Prep Biochem Biotechnol; 2021; 51(7):650-658. PubMed ID: 33226885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2: Targeted managements and vaccine development.
    Bakhiet M; Taurin S
    Cytokine Growth Factor Rev; 2021 Apr; 58():16-29. PubMed ID: 33293238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
    Rohilla S
    Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioengineered
    Chakraborty J; Banerjee I; Vaishya R; Ghosh S
    ACS Biomater Sci Eng; 2020 Dec; 6(12):6540-6555. PubMed ID: 33320635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral potential of nanoparticles for the treatment of Coronavirus infections.
    Sarkar J; Das S; Aich S; Bhattacharyya P; Acharya K
    J Trace Elem Med Biol; 2022 Jul; 72():126977. PubMed ID: 35397331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Antiviral Coatings for High-Touch Surfaces by Using Human Coronaviruses HCoV-229E and SARS-CoV-2.
    Butot S; Baert L; Zuber S
    Appl Environ Microbiol; 2021 Sep; 87(19):e0109821. PubMed ID: 34288707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
    Edwards AM; Baric RS; Saphire EO; Ulmer JB
    Science; 2022 Mar; 375(6585):1133-1139. PubMed ID: 35271333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives.
    Rashidzadeh H; Danafar H; Rahimi H; Mozafari F; Salehiabar M; Rahmati MA; Rahamooz-Haghighi S; Mousazadeh N; Mohammadi A; Ertas YN; Ramazani A; Huseynova I; Khalilov R; Davaran S; Webster TJ; Kavetskyy T; Eftekhari A; Nosrati H; Mirsaeidi M
    Nanomedicine (Lond); 2021 Mar; 16(6):497-516. PubMed ID: 33683164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges.
    Rana MM
    J Biomater Sci Polym Ed; 2021 Jun; 32(9):1219-1249. PubMed ID: 33787467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.
    Bhattacharyya P; Das S; Aich S; Sarkar J
    Front Biosci (Elite Ed); 2021 Dec; 13(2):272-290. PubMed ID: 34937314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed MEA
    Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.
    Ruenjaiman V; Hirankarn N; Palaga T
    Asian Pac J Allergy Immunol; 2021 Jun; 39(2):69-77. PubMed ID: 34174806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent Inactivation of Human Respiratory Viruses Including SARS-CoV-2 by a Photoactivated Self-Cleaning Regenerative Antiviral Coating.
    Kumar U; Fox CR; Kolanthai E; Neal CJ; Kedarinath K; Fu Y; Marcelo E; Babu B; Parks GD; Seal S
    ACS Appl Mater Interfaces; 2022 Sep; 14(36):40659-40673. PubMed ID: 36004755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and control strategies for COVID-19: Prospects and possibilities.
    Khan K; Yaqub T
    Pak J Pharm Sci; 2020 Jul; 33(4):1727-1730. PubMed ID: 33583808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.